IC
LXRX icon

Ikarian Capital’s Lexicon Pharmaceuticals LXRX Stock Holding History

Ikarian Capital’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$257K Hold
164,674
– – 0.02% 137
2025
Q4 		$189K Sell
164,674
-11,805
-7% -$16.2K 0.01% 154
2025
Q3 		$238K Hold
176,479
– – 0.02% 148
2025
Q2 		$167K Sell
176,479
-1,241,473
-88% -$804K 0.03% 118
2025
Q1 		$653K Sell
1,417,952
-132,048
-9% -$83.3K 0.08% 106
2024
Q4 		$1.14M Buy
+1,550,000
New +$1.87M 0.16% 104

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ikarian Capital's LXRX Position: Q1 2026 in Review

Ikarian Capital held its Lexicon Pharmaceuticals (LXRX) position steady in Q1 2026 at 164,674 shares worth $257K. The position accounts for 0.02% of the portfolio, ranked #137.

Ikarian Capital first reported a position in LXRX in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.14M in Q4 2024. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Ikarian Capital held 164,674 shares of Lexicon Pharmaceuticals worth $257K as of Q1 2026.
  • Ikarian Capital left its Lexicon Pharmaceuticals share count unchanged in Q1 2026.
  • Lexicon Pharmaceuticals made up 0.02% of Ikarian Capital's portfolio in Q1 2026, its #137 holding.
  • Ikarian Capital first reported a position in Lexicon Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Ikarian Capital's Lexicon Pharmaceuticals position peaked at $1.14M in Q4 2024.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.